Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health
Initiatives for its MammoView(TM) Product Line
BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets:
SNDY) is pleased to announce that the Company has received purchase orders for
its MammoView(TM) line of surgical endoscopy instruments from various
hospitals under Catholic Health Initiatives, Littleton, CO. Catholic Health
Initiatives is constructed of seventy-eight hospitals, including twenty-two
critical-access facilities and thirty rural hospitals that are the sole
providers of health care in their communities.
Catholic Health Initiatives is a national nonprofit health care system with
headquarters in Denver. The second-largest faith-based health care system in
the nation, Catholic Health Initiatives was formed in 1996 through the
alliance of four Catholic health systems seeking to strengthen and expand
their health ministry for the future. It was the first Catholic system to give
lay people a sponsorship role in its facilities. Today, Catholic Health
Initiatives provides health care and other services to a diverse mix of
sixty-nine urban and rural communities across the nation.
"We are delighted to be working with one of the best health care organizations
in the United States by providing them the latest instrumentation for breast
endoscopy," stated Bob Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy recently announced that the Company has taken the initial
steps to get the CE Marking for its FDA approved MammoView(TM) line of
surgical instruments. This will allow the MammoView(TM) line to be sold
throughout the European Economic Union (EEU), which represents 30% or $94
Billion of the worldwide demand for medical instruments.
For more information on Catholic Health Initiatives, please visit:
www.catholichealthinit.org
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to
develop and market breakthrough technology, applications, medical devices and
procedural techniques for the screening, diagnosis, treatment and management
of medical conditions. Backed by technical support, Solos' sales team can help
make the right buying decisions for the hospital, surgery center, or physician
office with its catalog of FDA Approved products. Additional information is
available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 27E of the
Securities Act of 1934. Statements contained in this release that are not
historical facts may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain. Actual
performance and results may differ materially from that projected or suggested
herein due to certain risks and uncertainties including, without limitation,
ability to obtain financing and regulatory and shareholder approval for
anticipated actions.
SOURCE Solos Endoscopy, Inc.
Brian Neff of Big Apple Consulting USA, +1-407-389-5900, Investor Relations
for Solos Endoscopy, Inc.
